Microscopic Tumor Cell Dissemination in Gastric Cancer

Surgery Today

Volumn 34, Issue 2, 2004, Pages 101-106

  Jonas, Sven ^a   Weinrich, Mirko ^a   Tullius, Stefan G ^a   Al Abadi, Hussein ^a   Steinbrich, Roman ^a   Radke, Cornelia ^a   Klupp, Jochen ^a   Neuhaus, Peter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Bone marrow; Gastric cancer; Pertioneal cavity; Tumor cell dissemination

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKERATIN;

BONE MARROW BIOPSY; CANCER DIAGNOSIS; CORRELATION ANALYSIS; DISSEMINATED CANCER; HUMAN; IMMUNOCYTOCHEMISTRY; INTRAOPERATIVE PERIOD; MICROSCOPY; PERITONEUM LAVAGE; PROGNOSIS; REVIEW; SAMPLING; STOMACH CARCINOMA; SURVIVAL RATE; TUMOR CELL;

BONE MARROW; CARCINOMA; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PERITONEAL LAVAGE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0442276170     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2666-4     Document Type: Review

References (27)

1. Shahon D-B, Horowitz S, Kelly WD. Cancer of the stomach: an analysis of 1 152 cases. Surgery 1956;39:204-10.
2. Lawrence W, McNeer G, Pack GT, Paglia MA, Ashley MP. End results and prognosis. In: McNeer G, Pack GT, editors. Neoplasms of the stomach. Philadelphia: Lippincott: 1967. p. 102-25.
3. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449-61.
4. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999;230:170-8.
5. Soga J, Kobayashi K, Saito J, Fujimaki M, Muto T. The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg 1979;3:701-8.
6. Jauch KW, Heiss MM, Gruetzner U, Funke I, Pantel K, Babic R, et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996;14:1818-7.
7. Maehara Y, Yamamoto M, Oda S, Baba H, Kusumoto T, Ohno S, et al. Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer. Br J Cancer 1996;73:83-7.
8. Juhl H, Stritzel M, Wroblewski A, Henne-Bruns D, Kremer B, Schmiegel W, et al. Immunocytological detection of micrometastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994;57:330-5.
9. Broil R, Lembcke K, Stock C, Zingler M, Duchrow M, Schimmelpenning H, et al. Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma. Langenbecks Arch Chir 1996;381:51-8.
10. Thorban S, Roder JD, Nekarda H, Funk A, Pantel K, Siewert JR. Disseminated epithelial cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J Surg 1996;20:567-73.
11. Uhr JW, Scheuerman RH, Street NE, Vitetta ES. Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 1997;3:505-9.
12. Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol 1995;59:226-9.
13. Maehara Y, Hasuda S, Abe T, Oki E, Kakeji Y, Ohno S, et al. Tumor angiogenesis and micrometastasis in bone marrow of patients with early gastric cancer. Clin Cancer Res 1998;4:2129-34.
14. International Union Against Cancer (UICC). In: Hermanek P, Sobin LH, editors. TNM classification of malignant tumors. Revised edition. Berlin: Springer; 1992.
15. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-29.
16. Schlimok G, Funke I, Pantel K, Strobel F, Lindemann F, Witte J, et al. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991;27:1461-5.
17. Hermanek P, Maruyama K, Sobin LH. Stomach carcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, et al., editors. Prognostic factors in cancer. Berlin Heidelberg New York: Springer; 1995. p. 47-64.
18. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988;75:110-2.
19. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996;347:995-9.
20. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
21. Siewert JR, Kestlmeier R, Busch R, Bottcher K, Roder JD, Muller J, et al. Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-7.
22. Schott A, Vogel I, Krueger U, Kalthoff H, Schreiber HW, Schmiegel W, et al. Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372-9.
23. Suzuki T, Ochiai T, Hayashi H, Nakajima K, Yasumoto A, Hishikawa E, et al. Importance of positive peritoneal lavage cytology findings in the stage grouping of gastric cancer. Surg Today 1999;29:111-5.
24. Ichikura T, Furuya Y, Tomimatsu S, Okusa Y, Ogawa T, Mukoda K, et al. Relationship between nodal stage and the number of dissected perigastric nodes in gastric cancer. Surg Today 1998;28:879-83.
25. Majima T, Ichikura T, Mochizuki H. Prognostic significance of the cytologic features of free cancer cells in the peritoneal cavity of patients with gastric cancer. Surg Today 2002;32:35-9.
26. Mizutani K, Kofuji K, Shirouzu K. The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer. Surg Today 2000;30:614-21.
27. Maehara Y, Kabashima A, Tokunaga E, Hasuda S, Oki E, Kakeji Y, et al. Recurrences and relation to tumor growth potential and local immune response in node-negative advanced gastric cancer. Oncology 1999;56:322-7.